PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Phathom’s Voquezna Triple PAK & Voquezna Dual PAK Receives the US FDA’s Approval for the Treatment of H. pylori Infection in Adults

Phathom’s Voquezna Triple PAK & Voquezna Dual PAK Receives the US FDA’s Approval for the Treatment of H. pylori Infection in Adult...

May 3, 2022

PharmaShots Interview: X4 Pharmaceuticals’ Paula Ragan Shares Insights on Mavorixafor for the Treatment of Multiple Immunodeficiencies

PharmaShots Interview: X4 Pharmaceuticals’ Paula Ragan Shares Insights on Mavorixafor for the Treatment of Multiple Immunodeficien...

May 3, 2022

Zydus’ Bortezomib Receives the US FDA’s Approval for the Treatment of Cancer

Zydus’ Bortezomib Receives the US FDA’s Approval for the Treatment of Cancer

May 3, 2022

$Ipsen’s Cabometyx Receives EC’s Approval as a 2L treatment for Radioactive Iodine-Refractory Differentiated Thyroid Cancer$

Ipsen’s Cabometyx Receives EC’s Approval as a 2L treatment for Radioactive Iodine-Refractory Differentiated Thyroid Cancer

May 3, 2022

Genesis Entered into a Collaboration with Lilly to Discover Novel Therapies for up to Five Targets

Genesis Entered into a Collaboration with Lilly to Discover Novel Therapies for up to Five Targets

May 3, 2022

Denali Partner Sanofi Reports the Patient Dosing in P-II (HIMALAYA) Study of SAR443820 for the Treatment of Amyotrophic Lateral Sclerosis

Denali Partner Sanofi Reports the Patient Dosing in P-II (HIMALAYA) Study of SAR443820 for the Treatment of Amyotrophic Lateral Sc...

May 3, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us